Consensus CONMED Corporation

Equities

CNMD

US2074101013

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
65.78 ^USD	+6.27%		-9.44%	-39.93%

Apr. 25	Wells Fargo Adjusts Price Target on CONMED to $77 From $98, Maintains Equalweight Rating	MT
Apr. 25	Needham Lowers Price Target on CONMED to $107 From $129, Notes Slight Guidance Cut Due to Currency, Keeps Buy Rating	MT

Evolution of the average Target Price on CONMED Corporation

Price target over the last 5 years

History of analyst recommendation changes

9e46ee605.CLqfSwvcIcmQTgxzpbYepUmNTTq-p73FC3hVLaYKYZg.Zuj4JzmofqLiImAL54JEwwHheQnTxc2ERk94aPwnAv186fsePukUkMUbRQ~872548549853e04fca6c6a6a8cb281e7

Analyst Recommendations on CONMED Corporation

Wells Fargo Adjusts Price Target on CONMED to $77 From $98, Maintains Equalweight Rating	Apr. 25	MT
Needham Lowers Price Target on CONMED to $107 From $129, Notes Slight Guidance Cut Due to Currency, Keeps Buy Rating	Apr. 25	MT
Needham Adjusts Price Target on CONMED to $129 From $119, Maintains Buy Rating	Feb. 01	MT
JPMorgan Cuts CONMED Price Target to $115 From $135, Maintains Overweight Rating	Feb. 01	MT
Piper Sandler Adjusts Price Target on CONMED to $130 From $145, Maintains Overweight Rating	23-10-27	MT
Wells Fargo Cuts Price Target on CONMED to $107 From $123, Maintains Equalweight Rating	23-10-26	MT
Needham Adjusts Price Target on CONMED to $140 From $139, Maintains Buy Rating	23-07-27	MT
Keybanc Adjusts Price Target on CONMED to $141 From $131, Maintains Overweight Rating	23-07-27	MT
Needham Raises Price Target on CONMED to $139 From $135, Keeps Buy Rating	23-06-05	MT
CL King Starts CONMED at Buy With $140 Price Target	23-05-22	MT
Piper Sandler Raises CONMED's Price Target to $128 From $118, Maintains Overweight Rating	23-04-27	MT
Wells Fargo Adjusts Price Target on CONMED to $119 From $96, Maintains Equal-Weight Rating	23-04-27	MT
Needham Adjusts Price Target on CONMED to $135 From $122, Reiterates Buy Rating	23-04-27	MT
Keybanc Adjusts Price Target on CONMED to $131 From $124, Maintains Overweight Rating	23-04-27	MT
CONMED Upgraded by KeyBanc to Overweight From Sector Weight, Price Target Set at $124; Firm Sees Financial Profile Improving	23-03-27	MT
ANALYST RECOMMENDATIONS : Caterpillar, Conmed, Corning, Model N, United Rentals...	23-03-27
Needham Raises Price Target on CONMED to $122 From $106, Maintains Buy Rating	23-02-03	MT
Piper Sandler Adjusts CONMED's Price Target to $118 From $108, Maintains Overweight Rating	23-02-03	MT
Needham Cuts Price Target on CONMED to $90 From $123, Citing Currency Headwind, Inflation, Peer Multiple Contraction; Buy Rating Kept	22-10-14	MT
Jefferies Starts CONMED at Hold With $85 Price Target	22-10-12	MT
Needham Trims CONMED's Price Target to $123 From $127 on Near-Term Earnings Dilution From Biorez Deal; Buy Rating Kept	22-08-02	MT
Piper Sandler Adjusts CONMED's Price Target to $118 From $160, Reiterates Overweight Rating	22-07-28	MT
Needham Adjusts CONMED's Price Target to $127 From $155, Noting Currency Headwinds, Keeps Buy Rating Amid Accelerating Growth	22-07-28	MT
Stifel Nicolaus Adjusts Price Target for CONMED to $110 From $160, Maintains Buy Rating	22-06-23	MT
Needham Lifts CONMED's Price Target to $155 From $150 on In2Bones Acquisition, Reiterates Buy Rating	22-05-05	MT